Lincare to pay $29M over false claims for improperly billing Medicare
By 
Jeff Dale2023-08-29T18:41:00
A Florida-based provider of oxygen equipment for patients with respiratory ailments agreed to pay $29 million to resolve allegations it violated the False Claims Act by fraudulently overbilling Medicare.
Lincare Holdings, a subsidiary of German multinational chemical corporation Linde, admitted to improperly billing Medicare, Medicare Advantage plans, and beneficiaries for leased oxygen equipment the company had already been reimbursed for by the government, U.S. Attorney for the Eastern District of Washington Vanessa Waldref announced in a press release Monday.
The settlement resolves a lawsuit brought under the qui tam provisions of the False Claims Act by two former Lincare employees, Benjamin Montgomery and Brandon Haugen, who will receive more than $5.6 million.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
News BriefLincare to pay $26M over Medicare billing violations
Lincare, a supplier of durable medical equipment, agreed to pay $25.5 million to settle allegations it billed federal health programs for the rental of ventilator machines after patients no longer needed to use them.
-
News BriefCardiac Imaging, CEO to pay $85M in DOJ false claims case
Cardiac Imaging and its chief executive agreed to pay a total of more than $85 million to settle charges levied by the Department of Justice addressing alleged violations of the False Claims Act regarding unlawful kickbacks.
-
News BriefDOJ orders Cigna to pay $172M over false claims to Medicare
Multinational health insurance company Cigna agreed to pay more than $172 million as part of a settlement with the Department of Justice addressing allegations it submitted and failed to withdraw false claims to Medicare.
More from Regulatory Enforcement
-
ArticleTariff evasion enforcement: The new FCPA
Companies that import goods into the United States will face heightened enforcement scrutiny for attempted acts of customs fraud, including tariff evasion, under the Trump administration. Thus, chief compliance officers and in-house counsel face a new kind of pressure to ensure they are mitigating risk in this area.
-
ArticleFormer COO of plastics importer faces up to five years for customs falsifications
The chief operating officer of a plastic resin importer has pleaded guilty to intentionally falsifying documents to avoid paying tariffs on goods from China, the Department of Justice (DOJ) announced.
-
ArticleCybercrime against banks and account holders takes hit from FBI
Federal investigators have announced progress in dismantling an online criminal operation that steals bank account information by mimicking legitimate bank websites.